Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 57c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $298.29 --0%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - basic: 29.4M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $0.23, $0.57 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $509 million versus the consensus estimate of $515 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Bernstein SocGen Group Resumes Illumina (ILMN) at Market Perform
- Trupanion (TRUP) Reiterated at Hold by Stifel After 'Eight Straight Years of Share Losses'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
